Insider trades
Abizer Gaslightwala, CEO of Akari Therapeutics AKTX, has filed 7 purchases and 0 sales on the open market. The latest trade was on 06/24.
Abizer Gaslightwala
CEO
- Company
- Akari Therapeutics AKTX
- First filing
- 24/12/27
- Trades
- 26 trades
- Buys / sales
- 7 / 0
- 12-month net buying
- No record
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AKTX | Open-market buy | 25/08/21–25/08/25 | 25/08/29 | 21,000 sh3 trades | $0.93avg. | $19,540 | +7.6% |
AKTX | Open-market buy | 25/06/23–25/06/24 | 25/06/25 | 6,146 sh2 trades | $1.16avg. | $7,119.93 | +2.3% |
| Open-market buy | 25/06/20 | 25/06/24 | 10,000 sh | $1.20 | $12,000 | +3.8% | |
| Open-market buy | 25/06/17 | 25/06/20 | 15,000 sh | $1.20 | $18,000 | +6.1% |